Publication
Neonatal stroke associated with de novo antiphospholipid antibody and homozygous 1298C/C methylenetetrahydrofolate reductase mutation
| dc.contributor.author | Rego Sousa, P. | |
| dc.contributor.author | Figueira, R. | |
| dc.contributor.author | Vasconcellos, R. | |
| dc.date.accessioned | 2021-01-12T16:11:35Z | |
| dc.date.available | 2021-01-12T16:11:35Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Antiphospholipid antibodies are a recognised prothrombotic risk factor associated with acute ischaemic infarction. Most autoimmune diseases are rare in infants, and in the neonatal period, autoimmunity is related to transplacental passage of maternal immunoglobulin G autoantibodies. Distinguishing between de novo and acquired autoimmunity has important therapeutic implications and is crucial for determining the prognosis. We present a case of a neonatal thrombotic stroke associated with de novo synthesis of antiphospholipid antibodies, a homozygous 1298C/C methylene-tetrahydrofolate reductase mutation and a double-homozygous plasminogen activator inhibitor 1 polymorphism (PAI-1 844A/A and 675 4G/4G), which may have increased the final thrombotic risk. Her mother was not positive for antiphospholipid antibodies. The authors highlight an unequivocal evidence of a de novo case of paediatric antiphospholipid antibody syndrome and emphasise the need for a thorough investigation in cases of neonatal stroke including molecular thrombophilia study. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.1136/bcr-2012-006451 | pt_PT |
| dc.identifier.issn | 1757-790X | |
| dc.identifier.uri | http://hdl.handle.net/10400.26/34671 | |
| dc.language.iso | eng | pt_PT |
| dc.publisher | BMJ | pt_PT |
| dc.subject | Antibodies, Antiphospholipid | pt_PT |
| dc.subject | Antiphospholipid Syndrome | pt_PT |
| dc.subject | Brain Ischemia | pt_PT |
| dc.subject | Female | pt_PT |
| dc.subject | Homozygote | pt_PT |
| dc.subject | Humans | pt_PT |
| dc.subject | Infant, Newborn | pt_PT |
| dc.subject | Methylenetetrahydrofolate Reductase (NADPH2) | pt_PT |
| dc.subject | Mutation | pt_PT |
| dc.subject | Plasminogen Activator Inhibitor 1 | pt_PT |
| dc.subject | Polymorphism, Genetic | pt_PT |
| dc.subject | Stroke | pt_PT |
| dc.subject | Madeira Island | pt_PT |
| dc.subject | Região Autónoma da Madeira | pt_PT |
| dc.subject | Portugal | pt_PT |
| dc.title | Neonatal stroke associated with de novo antiphospholipid antibody and homozygous 1298C/C methylenetetrahydrofolate reductase mutation | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | bcr2012006451 | pt_PT |
| oaire.citation.issue | nov14 2 | pt_PT |
| oaire.citation.startPage | bcr2012006451 | pt_PT |
| oaire.citation.title | Case Reports | pt_PT |
| oaire.citation.volume | 2012 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Neonatal stroke associated with de novo antiphospholipid.pdf
- Size:
- 138.32 KB
- Format:
- Adobe Portable Document Format
